Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT4UXPE)

DTT Name	MHC class I NK cell receptor 2DL1 (CD158A) DTT Info
Gene Name	KIR2DL1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
IPH-2101	DMDUVCZ	Multiple myeloma	2A83	Phase 2	[1]
IPH-2102	DMPBR0D	Acute myeloid leukaemia	2A60	Phase 2	[1]
mab 1-7F9	DMQOBH4	Multiple myeloma	2A83	Phase 2	[2]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide. Haematologica. 2015 Feb;100(2):263-8.
2	Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12879-84.